Access Now
Part I: Innovations for attaining consistent and reproducible results in 3D assays
3D cultures are an established method for various applications, but researchers continue searching for improvements. Regulatory updates allow for rapid expansion and tech innovations must keep pace. Dr. Kiesslich highlights approaches to generate bulk spheroids and organoids. Corning equips researchers with scaffold/scaffold-free solutions providing consistent and reproducible results.
Presenter:
Sascha Kiesslich, Ph.D.
Field Application Scientist
Corning Life Sciences
Part II: Patient-derived organoids: an emerging platform to de-risk immunotherapy development
Cancer treatments are being identified at record pace with eligible patients expanding. Patient-derived organoids (PDOs) preserve tumor-specific antigens that are lost in standard models, giving an excellent system to investigate engagement, action mechanisms and patient populations. Dr. Boj discusses the development of autologous PDO biobanks for testing immuno-oncological compounds and co-culture assays.
Presenter:
Sylvia Boj, Ph.D.
Chief Scientific Officer
HUB Organoids
Thank You
Thank you for your interest. You may presentation using the link below. A confirmation email with the link to the e-book will also be sent to you as well.